Recall Register

Food, drugs, devices › Ortho-Clinical Diagnostics

Device recall: VITROS Immunodiagnostic Products CK-MB Calibrators, REF 128 6293, IVD, Ortho-Clinical Diagnostics High Wycombe HP12 4DP,

FDA enforcement event 64901 · Class III · initiated 3 Apr 2013 · status Terminated · terminated 2 Mar 2017

DeviceVoluntary: Firm initiated1 product recordRochester, NY

FDA enforcement event 64901 is a device recall by Ortho-Clinical Diagnostics of Rochester, NY, initiated 3 Apr 2013 and classified Class III, with 1 product record.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 5% of the 1,236 device enforcement events initiated in 2013 carry the same class.

Status: Terminated, terminated 2 Mar 2017. Initiation: voluntary: firm initiated. Ortho-Clinical Diagnostics has 105 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Ortho-Clinical Diagnostics, Rochester, NY.

Reason for recall

"Internal testing demonstrated that opened-reconstituted VITROS CK-MB Calibrators stored at -20 degrees Celsius (-4 degrees Farenheit) generated invalid calibrations that were detected by positively biased quality control results."

Distribution

"Worldwide Distribution - Nationwide including Puerto Rico, and the countries of Australia, Bermuda, Brazil, Canada, Chile, China, Colombia, England, France, Germany, India, Italy, Japan, Mexico,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1337-2013VITROS Immunodiagnostic Products CK-MB Calibrators, REF 128 6293, IVD, Ortho-Clinical Diagnostics High Wycombe HP12 4DP, UK For use in the calibration of the VITROS ECi/ECiQ Immunodiagnostic Systems, the VITROS 3600 Immunodiagnostic System and the VITROS 5600 Integrated System for the quantitative measurement of…Domestic: 3019 units, Foreign: 905 unitsClass IIITerminated29 May 2013

Context

5%of 2013 device events are Class III1,236 events that year
1product record in this eventfirm median: 1
105events on this register for the firm

Other enforcement events for Ortho-Clinical Diagnostics

InitiatedProduct (first record)TypeClassRecords
27 Feb 2024VITROS Performance Verifier IDeviceClass II2
5 Jun 2023VITROS Immunodiagnostic Products Troponin I ES Reagent PackDeviceClass II2
8 May 2023VITROS Chemistry Products Calibrator Kit 20-in vitro diagnostic use only. VITROS Chemistry Products Calibrator Kit 20- UDeviceClass II1
20 Jul 2020VITROS XT3400 Chemistry System, Product code 6844458DeviceClass II2
17 Jul 2020VITROS Anti-SARS-CoV-2 Total Reagent, COV2TOT, VITROS CoV2T. Catalog number 6199922, UDI 10758750033386 - Product Usage:DeviceClass II2
13 Jul 2020VITROS Chemistry Products TBIL Slides- 5 PACK/300 SLDS In vitro Diagnostic quantitatively measure total bilirubin (TBIL)DeviceClass II3
20 May 2020VITROS 3600 Immunodiagnostic System Software Versions 3.3.3 and below Product Code: 6802783, Unique Identifier: 10758750DeviceClass II5
11 May 2020VITROS Chemistry Product AMYL Slides Reagent, AMYLASE/5 PACK/300 SLDS, Product Code 1202670, UDI # 10758750008513 - ProdDeviceClass II4
1 Apr 2020VITROS Chemistry Products CKMB Slides, Creatine Kinase MB, Product Code 805 8232-300 slides, UDI Number 10758750004294 -DeviceClass II2
10 Mar 2020VITROS Immunodiagnostic Products TT4 Reagent Pack, Product Code 8744468DeviceClass III1

All 105 events for Ortho-Clinical Diagnostics

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Internal testing demonstrated that opened-reconstituted VITROS CK-MB Calibrators stored at -20 degrees Celsius (-4 degrees Farenheit) generated invalid calibrations that were detected by positively biased quality control results."

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - Nationwide including Puerto Rico, and the countries of Australia, Bermuda, Brazil, Canada, Chile, China, Colombia, England, France, Germany, India, Italy, Japan, Mexico,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 2 Mar 2017. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.